Opinion
By the Alliance for a Stronger FDA
The President is going to release his Fiscal Year (FY) 2022 budget request today (May 28, 2021).
In advance of receiving the
Acting FDA Commissioner Dr. Janet Woodcock spoke recently to the Alliance for a Stronger FDA with some assurances for the food safety side of her house.
The acting commissioner for
Opinion
Editor’s note: The Alliance for a Stronger FDA recently offered this analysis of the Food and Drug Administration’s FY 2021 funding.
The current fiscal year (FY) 2021
Opinion
Editor’s note: This column was originally posted by the Alliance for a Stronger FDA and is republished here with permission.
Today, many of us will be sitting down
The Alliance for A Stronger FDA, a non-profit organization that has been rattling the fiscal cages in Washington D.C. for more than a decade, isn’t buying the line
The Alliance for a Stronger FDA — which unites consumers, patient groups and industry in advocating for Food and Drug Administration (FDA) funding — Wednesday thanked the U.S. House appropriators for
Editor’s note: This was originally published May 26, 2017, on the website of the Alliance for a Stronger FDA. The alliance is committed to an ongoing, multi-year effort with
Editor’s note: This column includes information from an “Advocacy at a Glance” posting by the Alliance for a Stronger FDA and analysis and commentary by Steven Grossman, deputy executive
(This commentary by Steven Grossman, deputy executive director of the Alliance for a Stronger FDA, originally appeared in the Alliance’s Friday Update of Nov. 21, 2014, and is reposted
